Disability progression in multiple sclerosis is associated with plasma neuroactive steroid profile.

Cheng, C; Gomez, D; McCombe, J A; Smyth, P; Giuliani, F; Blevins, G; Baker, G B; Power, C

Cheng, C; Gomez, D; McCombe, J A; Smyth, P; Giuliani, F; Blevins, G; Baker, G B; Power, C.

Affiliation

Cheng C; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.
Gomez D; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
McCombe JA; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.
Smyth P; Department of Medicine (Neurology), HMRC 6-11, University of Alberta, Edmonton, AB, Canada.
Giuliani F; Department of Medicine (Neurology), HMRC 6-11, University of Alberta, Edmonton, AB, Canada.
Blevins G; Department of Medicine (Neurology), HMRC 6-11, University of Alberta, Edmonton, AB, Canada.
Baker GB; Department of Medicine (Neurology), HMRC 6-11, University of Alberta, Edmonton, AB, Canada.
Power C; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.

Neurol Sci ; 42(12): 5241-5247, 2021 Dec.

Article de En | MEDLINE | ID: mdl-33829329

Sujet(s)
Mots clés

Amino acids; Clinically isolated syndrome; Disability progression; Multiple sclerosis; Neuroactive steroids

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies démyélinisantes / Sclérose en plaques récurrente-rémittente / Neurostéroïdes / Sclérose en plaques Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Neurol Sci Sujet du journal: NEUROLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Canada Pays de publication: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google